Stockpicker Comparison Tool

Stock A

VRTX ×

Stock B

GSK ×

Stock C

Stock D

Revenue Growth VRTX 12.45% ▲ 4.63% GSK 5.30% ▲ 3.79% Gross Margin VRTX 85.33% ▼ -1.52% GSK 73.05% ▼ -2.37% Free Cash Flow VRTX $1.01B ▼ -$281.50M GSK $2.96B ▲ $2.02B Net Debt / EBITDA VRTX -1.08 ▼ -0.10 GSK 1.38 ▼ -0.44 Operating Margin VRTX 37.41% ▼ -0.69% GSK 5.72% ▼ -24.34% P/E Ratio VRTX 27.59 ▲ 2.74 GSK 16.82 ▲ 3.67

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.